New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry
Veriheal
APRIL 11, 2022
Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. Drug Enforcement Agency (DEA). Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials.
Let's personalize your content